Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation.
Novartis Pharma AG, Basel, Switzerland.
Martin
M
Merschhemke
Novartis Pharma AG, Basel, Switzerland.
Davorka
D
Tomic
Novartis Pharma AG, Basel, Switzerland.
Norman
N
Putzki
D000068876:Fingolimod Hydrochloride; D006801:Humans; D007166:Immunosuppressive Agents; D009103:Multiple Sclerosis; D020529:Multiple Sclerosis, Relapsing-Remitting
D007166:Immunosuppressive Agents; D000068876:Fingolimod Hydrochloride